share_log

CareCloud, Inc. Partners With DrFirst to Enhance Medication Adherence and Reduce Healthcare Costs

CareCloud, Inc. Partners With DrFirst to Enhance Medication Adherence and Reduce Healthcare Costs

CareCloud公司與DrFirst合作,以提高服藥依從性,並降低醫療保健成本。
GlobeNewswire ·  07/17 08:00

SOMERSET, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, is pleased to announce the expansion of its strategic partnership with health technology pioneer DrFirst to now include integrated RxInform functionality, which is designed to improve medication adherence by increasing patient engagement and reducing the burden of high prescription costs.

CareCloud,Inc.(納斯達克證券代碼爲:CCLD,CCLDO,CCLDP)是醫療科技和人工智能領域的領導者,爲全美的醫療機構和衛生系統提供解決方案。很高興地宣佈,我們與健康科技先驅DrFirst的戰略合作關係現已擴展到包括RxInform功能的整合,旨在通過提高患者參與度和降低高處方成本的負擔來改善藥品依從性。

"Through this new functionality, our platform is better positioned to reduce prescription abandonment by, among other things, addressing the financial challenges patients face when insurance does not fully cover medication costs through enabling our providers to generate relevant notifications and coupons to their patients," said Al Nardi, CareCloud's SVP Strategy and Chief Compliance Officer. "These coupons can substantially lower out-of-pocket costs for the millions of patients on CareCloud's platform. This initiative not only alleviates financial burdens but also encourages adherence to prescribed treatments, leading to better health outcomes."

"通過該新功能,我們的平台更好地定位於,在其他事項之外,通過讓我們的提供者向他們的患者生成相關的通知和優惠券來解決患者在保險不完全覆蓋藥品成本時面臨的財務挑戰,從而減少處方棄置。"CareCloud的戰略副總裁兼首席合規官Al Nardi表示:"這些優惠券可以大大降低在CareCloud平台上的數百萬患者的個人成本。這項計劃不僅緩解了財務負擔,也鼓勵了按處方治療,從而產生更好的健康結果。"

CareCloud currently offers fully integrated DrFirst e-prescribing for controlled substances (EPCS) and prescription drug monitoring program (PDMP) solutions to its network of providers. With the incorporation of RxInform, it enhances its seamless notification system that keeps patients informed throughout the prescription process. Patients now receive text alerts when their prescription is sent, when it is ready for pick-up, and when coupons and discount cards are available, ensuring timely updates and convenience. By offering coupons, discount cards and reminders, CareCloud aims to support its practices who are striving to alleviate the negative effects of poor medication adherence.

CareCloud目前爲其提供者網絡提供完全集成的DrFirst壓控處方(EPCS)和處方藥監控計劃(PDMP)解決方案。通過RxInform的整合,它增強了無縫通知系統,使患者在整個處方過程中始終保持了解。現在,患者在處方發送時,準備取藥時和優惠券和折扣卡可用時均會收到短信提醒,確保及時更新和便利。通過提供優惠券、折扣卡和提醒,CareCloud旨在支持努力減輕藥品依從性負面影響的實踐。

DrFirst CEO G. Cameron Deemer explained, "When patients don't pick up their prescriptions, it's typically because they forget, they can't afford the medication, or they are unsure about the instructions from their last office visit. Now doctors on the CareCloud platform can engage directly with patients on their mobile devices minutes after a new prescription is sent to the pharmacy. Over the past six years, RxInform has consistently received a satisfaction rate of 95% based on more than 20 million patient ratings."

DrFirst CEO G. Cameron Deemer 解釋道:"當患者不取藥時,通常是因爲他們忘記了,他們無法負擔藥物,或者他們不確定上次就診的指示。現在,CareCloud平台上的醫生可以在向藥局發送新處方後的幾分鐘內直接與患者進行聯繫。在過去的六年中,RxInform一直保持了95%的滿意度,基於2000萬患者評價。"

The expansion of this strategic partnership between CareCloud and DrFirst represents a significant advancement towards enhancing patient engagement and medication adherence. This collaboration is poised to reduce financial barriers, improve prescription pick-up rates, and ultimately lead to better health outcomes.

CareCloud和DrFirst戰略合作的擴展代表着提高患者參與度和藥品依從性的重要進展。這種合作關係可以減輕財務障礙,改善處方領取率,並最終導致更好的健康結果。

About CareCloud

關於CareCloud

CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) brings disciplined innovation and generative AI solutions to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at .

CareCloud(Nasdaq證券代碼:CCLD、CCLDP、CCLDO)在醫療保健業務中帶來了有紀律的創新和生成性人工智能解決方案。我們的技術解決方案套件幫助客戶提高財務和運營業績,簡化臨床工作流程並改善患者體驗。四萬多個提供者依靠CareCloud幫助他們改善患者護理,同時減少行政負擔和運營成本。了解我們的產品和服務,包括收入循環管理(RCM)、實踐管理(PM)、電子病歷(EHR)、商業智能、患者體驗管理(PXM)和數字健康,請訪問.

About DrFirst

關於DrFirst

Since 2000, healthcare IT pioneer DrFirst has empowered providers and patients to achieve better health through intelligent medication management. We improve healthcare efficiency and effectiveness by enhancing e-prescribing workflows, improving medication history, optimizing clinical data usability, and helping patients start and stay on therapy. In the last few years, DrFirst has won over 25 awards for excellence and innovation, including winning Gold in the prestigious Edison Awards in 2023, recognizing our game-changing use of AI to streamline time-consuming healthcare workflows and prevent medication errors. Our solutions are used by more than 350,000 prescribers, 71,000 pharmacies, 270 EHRs and health information systems, and over 2,000 hospitals in the U.S. and Canada. To learn more, visit DrFirst.com and follow @DrFirst.

自2000年以來,醫療保健先驅DrFirst通過智能化藥物管理使提供者和患者實現更好的健康。我們通過增強電子處方工作流程、改進藥物史、優化臨床數據可用性以及幫助患者開始和堅持治療來提高醫療效率和有效性。在過去幾年中,DrFirst贏得了25多個卓越和創新獎項,包括在2023年贏得了著名的愛迪生獎金(Edison Awards)的金獎,以表彰我們運用人工智能改善了耗時的醫療保健工作流程和預防藥物誤用的方法。我們的解決方案由超過350,000個開藥人員、71,000家藥店、270個 EHRs和健康信息系統以及美國和加拿大的2,000多家醫院使用。了解更多信息,請訪問DrFirst.com並關注@ DrFirst。

Follow CareCloud on LinkedIn, Twitter and Facebook.

在LinkedIn、Twitter和Facebook上關注CareCloud。

SOURCE CareCloud
Company Contact:
Al Nardi
anardi@carecloud.com

消息來源CareCloud
公司聯繫人:
Al Nardi
anardi@carecloud.com


声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論